Navigation Links
VAP Test Demonstrates Value of Fish Oil in Reducing Heart Risk for Super Bowl Champs
Date:2/19/2009

Advanced cholesterol test helps usher in new era of specialized test for cardiac risk assessment

BIRMINGHAM, Ala., Feb. 19 /PRNewswire/ -- For the Pittsburgh Steelers, adding a heart-healthy supplement to their diet may have given them the boost to win Super Bowl XLIII. That's according to a clinical study proving that fish oils dramatically improve cholesterol levels in professional football players. Findings were published January in the inaugural issue of Sports Health: A Multi-Disciplinary Approach.

The two-year study titled Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players evaluated 36 professional NFL football players, ages 23 to 41, from the Pittsburgh Steelers. Researchers assessed emerging cardiovascular risk factors, as found in the specialized VAP(R) Cholesterol Test, to determine whether omega-3 EFAs (essential fatty acids) found in fish oil can reduce these factors.

During a two month period of the regular 2006-2007 football season, each participant in the treatment group was given 2,560 mg/day of mixed EPA/DHA omega-3 fatty acid supplements in the form of fish oil soft gels.

Results showed that the omega-3 oil raised the athletes' high-density lipoproteins (HDL--good cholesterol) and lowered triglycerides and other atherogenic subfractions. Elevated levels of triglycerides are associated with diabetes and cardiovascular disease. These results suggest a strong benefit for lessening heart disease risk factors in football players and possibly other athletes throughout their active years, study authors said.

Measurement of emerging clinical and lipid risk factors in the study was done with the VAP (Vertical Auto Profile) Cholesterol Test from Atherotech, Inc. Such detailed cholesterol profiling has the ability to more accurately identify parents' true risk of heart disease, allowin
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
2. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
3. Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences
4. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
5. Antheras Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease
6. RVX-208 Data Demonstrates Increase in Functional HDL Particles
7. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
8. Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
9. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
10. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
11. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of ... Cassian Yee , M.D., Professor, Department of Melanoma ... of Texas MD Anderson Cancer Center joined its scientific ... Immunology, Division of Cancer Medicine, and Director, Solid Tumor ... University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... GA (PRWEB) May 06, 2015 ... based on the products of cells grown under ... its 105F immunomodulatory treatment candidate for melanoma during ... Meeting, taking place May 6-9, 2015 in Atlanta, ... multipotent cells produce a soluble material with anti-oncologic ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and sample ... major content upgrade to its bestselling, Commercial Off-The-Shelf (COTS) ... a significant advancement of FreezerPro® system , ... also simplifying , New FreezerPro® VM ... Download available immediately for free to “Gold” support subscribers ...
(Date:5/5/2015)... 5, 2015 Roka Bioscience, Inc. (NASDAQ: ROKA ... solutions for the detection of foodborne pathogens,  today announced that ... of America Merrill Lynch 2015 Health Care Conference on May ... Encore at the Wynn, Las Vegas NV. ... will be available through the investor relations section of Roka ...
Breaking Biology Technology:Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2RURO Releases version 7 of FreezerPro® software 2
... Oriental,Bioengineering (NYSE: AOB ) announced today that ... decision to cancel its,convertible preferred stock offering at ... resulting in terms that were not acceptable to,the ... made in this press release are forward-looking and ...
... 5 Cardiac Science,Corporation (Nasdaq: CSCX ... diagnosis,resuscitation, rehabilitation, and informatics products, announced today,that ... Needham & Company Biotechnology,and Medical Technology Conference ... senior vice president and chief financial officer, ...
... Anesiva,Inc. (Nasdaq: ANSV ) today announced ... NF-kappa B Decoy (NF-kB Decoy) program, which includes ... (TFT). NF-kB Transcription Factor Decoy inhibits NF-kappa B, ... such as inflammatory,bowel disease (IBD), eczema, rheumatoid arthritis, ...
Cached Biology Technology:Cardiac Science to Present at Needham Biotechnology & Medical Technology Conference 2Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 2Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 3
(Date:4/10/2015)... , April 10, 2015 ... addition of the "Security Competitive Profiles - NEC" ... http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to supply ... to the market, with a company focus on the ... anticipated. Winning opportunities in the ...
(Date:4/2/2015)... April 2, 2015 At its 2015 ACMG ... City , the American College of Medical Genetics ... directors to its Board.  Members of the ACMG Board ... for forming and advancing its policies and programs. ACMG ... "It,s an eventful time in medical genetics ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications ... a global provider of Software Defined Network Architecture (ET ... announced total revenue of approximately $20.4 million for the ... restated $19.5 million for the year ended December 31, ... 2014, the Company had completed its multi-year transition away ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... tiger snakes stranded for thousands of years on tiny islands ... twice the size of their mainland cousins. Now, new research ... of these elapids was driven by the need to have ... at 35 inches (89 cm) long, patrol swampy areas in ...
... CHAMPAIGN, Ill. Miscanthus grasses are used in ... fuels. They also belong to a prominent grass family that ... maps of Miscanthus sinensis (an ornamental that ... biofuels crop) are a first step toward sequencing the ...
... 15, 2012) This fall, Drexel Environmental Science students will ... locally and across the globe as a result of ... Natural Sciences. Out of the affiliation comes the Department ... will work and learn among some of the world,s ...
Cached Biology News:Big-mouthed babies drove the evolution of giant island snakes 2Big-mouthed babies drove the evolution of giant island snakes 3Maps of Miscanthus genome offer insight into grass evolution 2Maps of Miscanthus genome offer insight into grass evolution 3New museum-university partnership ushers in new era of environmental science education 2
... revolutionizes imaging software for the microscopy ... microscopes, cameras, components and peripherals with ... tools. Its intuitive interface simplifies workflow ... while providing powerful features such as ...
...
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine....
... incorporates the critical design features demanded by ... research. The Series 4000 delivers improved performance, ... discoveries to biomarker assays all on the ... to fit into the research plans of ...
Biology Products: